Regenxbio (RGNX) Current Taxes (2018 - 2022)

Regenxbio's Current Taxes history runs 5 years deep, the most recent figure standing at $12.7 million for Q1 2022.

• On a quarterly basis, Current Taxes rose 216.4% year-over-year to $12.7 million in Q1 2022; TTM through Mar 2022 was $12.7 million, a 216.4% increase from a year earlier, with the FY2021 full-year figure at $11.3 million, up 261.24% from the prior year.
• Current Taxes improved to $12.7 million in Q1 2022 per RGNX's latest filing, from $11.3 million in the prior quarter.
• Across five years, Current Taxes topped out at $12.7 million in Q1 2022 and bottomed at $508000.0 in Q3 2019.
• The 5-year median for Current Taxes is $1.8 million (2018), against an average of $3.8 million.
• Across the five-year window, Current Taxes sank 76.88% in 2019 and surged 261.24% in 2021, its largest moves.
• Year by year, Current Taxes stood at $726000.0 in 2018, then sank by 30.03% to $508000.0 in 2019, then jumped by 517.13% to $3.1 million in 2020, then jumped by 261.24% to $11.3 million in 2021, then grew by 11.89% to $12.7 million in 2022.
• Per Business Quant, the three latest RGNX Current Taxes figures stand at $12.7 million (Q1 2022), $11.3 million (Q4 2021), and $4.0 million (Q1 2021).